About
Longenesis is a Riga-based digital health company founded in 2017 that builds platforms connecting pharmaceutical companies, healthcare providers, and patients to accelerate biomedical research. Its three core products — Curator, Themis, and Engage — enable privacy-preserving patient cohort discovery, consent management, and real-world evidence generation. The company has positively impacted over 850,000 patients across the EU and MENA, holds partnerships with Medtronic and Novartis, and has raised over €1 million in seed funding. It won second place at the EIT Health Catapult programme and earned an AWS Industry Award in 2023.
Investors 1
- Imprimatur Capital Fund Management Venture Capital · Riga
Recent news
- Latvian startup Longenesis dominates Supernova Challenge 2.0 with $100,000 victory 2024-10-18 · Investment and Development Agency of Latvia (LIAA)